Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings |
Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice | Germany | NCT07508007 | |
Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China |
Chronic Myeloid Leukemia in Chronic Phase | China | NCT07375355 | |
A Study to Assess the Effects of Zigakibart on IgA Nephropathy. |
Immunoglobulin A Nephropathy (IgAN) | Phase2 | Brazil China Germany Italy Japan Poland South Korea Spain Taiwan United States View all |
NCT07146906 |
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia |
Schizophrenia | Phase2 | Bulgaria United States |
NCT07467993 |
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo |
Non-segmental Vitiligo | Phase2 | Australia Canada China France Germany India Italy Japan Netherlands Spain United States View all |
NCT07431177 |
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease |
Huntington Disease | Phase3 | Argentina Canada China Israel South Korea Switzerland Taiwan United Kingdom United States View all |
NCT07326709 |
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration |
Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase2 | Australia Bulgaria Canada Czechia France Germany Hungary Italy Japan Poland Puerto Rico Romania Spain United Kingdom United States View all |
NCT07441642 |
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea |
Hidradenitis Suppurativa, Pediatric Plaque Psoriasis, Juvenile Idiopathic Arthritis | South Korea | NCT07243782 | |
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) |
Metastatic Prostate Cancer | China | NCT07290270 | |
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Germany | NCT05344469 |